Voyageur Pharmaceuticals Ltd.
VYYRF · OTC
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $5,787 | $10,131 | $9,412 |
| - Cash | $166 | $2 | $32 | $813 |
| + Debt | $40 | $40 | $26 | $42 |
| Enterprise Value | -$125 | $5,825 | $10,125 | $8,641 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$2 | -$3 | -$2 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$1,221 | -$1,751 | -$2,043 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$1,399 | -$1,754 | -$2,051 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.012 | -0.011 | -0.016 | -0.022 |
| % Growth | -15.9% | 34.4% | 24.9% | – |
| Operating Cash Flow | -$302 | -$991 | -$1,719 | -$1,654 |
| Capital Expenditures | -$166 | -$0 | -$283 | -$432 |
| Free Cash Flow | -$302 | -$991 | -$2,002 | -$2,086 |